At Applied Biology our mission is to bring ideas to life that lead to life-changing therapies.
News
- Andy Goren
- ·
- 14 March 2022
Authorization and Donation of Proxalutamide and Hospital Equipment
Donation made to the Republic of Ghana, Minsitry of Health, by Prof. Andy Goren and Team from the University of Marconi – Rome, Italy
- Reuters
- ·
- 23 June 2021
Prostate Cancer Drug May Improve COVID-19 Survival Rate
Proxalutamide clinical trial in Brazil improved the survival of hopitalized COVID-19 patients.
- The Weather Channel
- ·
- 9 May 2021
Study: AR Gene May Increase COVID-19 Severity
Researchers have found that men with Androgenetic Alopecia are more prone to being hospitalised and at risk for ICU admission due to COVID-19.
- US News
- ·
- 6 May 2021
Androgen Receptor (AR) Gene Tied to Balding May Also Raise COVID Risks for Men
Among hospitalized men with COVID-19, 79% presented with androgenetic alopecia compared to 31%-53% that would be expected in a similar aged match population.
- Andy Goren, MD
- ·
- 6 May 2021
New Genetic Biomarkers Related to Hair Loss can Determine the Severity of COVID-19 in Men
与脱发有关的新型遗传生物标记物可确定男性COVID-19的严重程度.
- Daily Mail
- ·
- 6 May 2021
Bald Men are up to 2.5 Times more Likely to Suffer Severe COVID-19
Severe cases of COVID-19 are 2.5 times more likely in men with male-pattern baldness than those with a full head of hair.
- Andy Goren, MD
- ·
- 9 April 2021
Bolsonaro Highlights Postive Results of the Proxlutamide remedy against Covid-19
The study by the Samel Group in partnership with Applied Biology pointed out that Proxlutamide reduced the mortality rate from Covid-19 by 92%.
- Andy Goren, MD
- ·
- 1 April 2021
Brazilian President Bolsonaro discusses Proxlutamide in national address.
Begins at 6:59 mark during address.
- Andy Goren, MD
- ·
- 17 March 2021
Bolsonaro e ministros teriam conversado sobre uso de remédio de Covid em testes
A proxalutamida é um fármaco indicado no tratamento de câncer de próstata e de mama e é estudado no tratamento da Covid-19
- Andy Goren, MD
- ·
- 26 February 2021
Applied Biology and Samel to Inaugurate the First COVID-19 Clinical Research Center in the Brazilian Amazon State
EMERGENT VARIANTS OF SARS-COV-2 IN THE BRAZILIAN AMAZON PRESENT UNIQUE OPPORTUNITY TO STUDY TREATMENTS FOR COVID-19
- Andy Goren, MD
- ·
- 7 February 2021
Collaborating with Leading Scientists from Brazil and the United States, Samel to Test Tools Against Coronavirus
The Antiandrogen, Proxalutamide, is being Tested as a Barrier to the Male Hormone Proven to Work Against Covid-19.
- Andy Goren, MD
- ·
- 7 February 2021
Nova droga contra Covid-19 pode vir do tratamento do câncer
- Andy Goren, MD
- ·
- 7 February 2021
Remédio contra a Covid-19 está sendo testado por pesquisador americano em hospital de Manaus
- Andy Goren, MD
- ·
- 5 February 2021
Applied Biology Scientists to Donate Medical Supplies to Healthcare Workers and Patients in COVID-19 Stricken Manaus
AS PART OF A MISSION TO STUDY NEW COVID-19 VARIANTS IN MANAUS, BRAZIL, APPLIED BIOLOGY SCIENTISTS DONATE MUCH NEEDED MEDICAL SUPPLIES
- Andy Goren, MD
- ·
- 28 January 2021
Applied Biology Receives IRB Approval to Study a Potential Breakthrough Therapy for Hospitalized COVID-19 Patients
PROXALUTAMIDE AS A POTENTIAL TREATMENT FOR HOSPITALIZED COVID-19 PATIENTS
- Andy Goren, MD
- ·
- 27 January 2021
Applied Biology Appoints Raj Airey to its Board of Directors
RAJ AIREY TO JOIN APPLIED BIOLOGY’S BOARD OF DIRECTORS
- Andy Goren, MD
- ·
- 27 January 2021
Applied Biology Appoints Raj Airey to its Board of Directors
RAJ AIREY TO JOIN APPLIED BIOLOGY’S BOARD OF DIRECTORS
- Andy Goren, MD
- ·
- 19 January 2021
JEADV Dermatology Podcast
Anti-androgens in the treatment of severe COVID-19
- Andy Goren, MD
- ·
- 7 January 2021
COVID-19 AndroCoV Protocol Pioneered by Applied Biology and Brazilian Scientists Adopted by the Brazilian Government
BREAKTHROUGH DISCOVERY BY APPLIED BIOLOGY SCIENTISTS PAVES WAY TO POTENTIALLY MORE EFFICIENT TREATMENT FOR COVID-19
- Andy Goren, MD
- ·
- 6 January 2021
Ministério da Saúde prepara ações para reforço do SUS em Manaus
Reorganização dos postos de saúde, recrutamento de médicos e abertura de novos leitos de UTI estão entre as iniciativas para enfrentamento da pandemia no município; estratégia de vacinação para o Amazonas também será apresentada
- Andy Goren, MD
- ·
- 28 November 2020
Dr. Andy Goren Presents COVID-19 Research to Brazil Minister of Science
Dr. Goren and Astronaut Marcos Pontes, State Minister of Science of Brazil, met to discuss anti-androgens as a treatment for COVID-19.
- Andy Goren, MD
- ·
- 28 September 2020
Applied Biology in Collaboration with Researchers at University Hospital Ramon y Cajal Hospital Announce Results from Study of Androgen Receptor Genetics in Hospitalized COVID-19 Patients
STUDY CONFIRMS ASSOCIATION OF ANDROGEN RECEPTOR WITH COVID-19 DISEASE SEVERITY
- Andy Goren, MD
- ·
- 22 September 2020
Applied Biology and Corpometria Institute Receive National IRB Approval to Study a Potential Breakthrough Therapy for COVID-19
NEXT GENERATION ANTI-ANDROGEN AS A POTENTIAL TREATMENT FOR COVID-19
- Andy Goren, MD
- ·
- 14 July 2020
Applied Biology and Kintor to Collaborate on the use of Proxalutamide for the Treatment of COVID-19
IN A RACE TO FIND A TREATMENT FOR COVID-19, KINTOR HAS TEAMED WITH APPLIED BIOLOGY TO STUDY ITS LEAD ANTI-ANDROGEN AGAINST COVID-19
- BBC Radio
- ·
- 6 June 2020
BBC Interview: The Possible Link Between Covid-19 and the Androgen Receptor
Listen to the Phil Kennedy interview of Professor Andy Goren and Dr. Carlos Wambier.
- The Bald Truth
- ·
- 9 June 2020
COVID-19 Symptoms Appear to be Worse in Bald Men
Watch the Spencer Kobren Interview of Applied Biology's CMO Andy Goren and Fellow Researchers.
- Dermasphere
- ·
- 6 July 2020
COVID, Androgens, Alopecia, and Sunlight
A Conversation with Carlos Wambier and Andy Goren
- Dermasphere
- ·
- 12 June 2020
Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
Listen to Luke Johnson and Michelle Tarbox, MD on the Dermasphere Podcast (Episode 29) Discussing Applied Biology and Brown University's Covid-19 Research Article — Starting at 43:44 Timestamp.
- ABC News Australia
- ·
- 24 June 2020
Why are More Bald Men Hospitalized for Coronovirus?
The answer could point to a treament.
- Miami Herald
- ·
- 23 June 2020
Bald Men Might Have a Higher Risk of Mortality from COVID-19, Studies Say
Women's levels of androgen are lower than men's, which could explain why they don’t seem to get it as badly in some cases.
- WebMD
- ·
- 12 June 2020
Androgens are the Gateway for Coronovirus to Enter Cells
Male Baldness May Increase Severe COVID-19 Risk.
- FOX NEWS
- ·
- 12 June 2020
Bald Men May be Harder Hit By Coronovirus
Baldness May be a Perfect Predictor of Severity.
- NY POST
- ·
- 11 June 2020
Coronovirus Hits Bald Men Harder?
Scientists believe that androgens may boost the ability of coronavirus to attack cells.
- Forbes Magazine
- ·
- 6 June 2020
Coronovirus Poses a Higher Risk for Bald Men
COVID-19 research is showing that men, particularly bald men, have a worse trajectory.
- Science Magazine
- ·
- 3 June 2020
Coronovirus Hits Men More Severely, Here's Why...
Studying the link between androgens and the severity of COVID-19.
- Andy Goren, MD
- ·
- 2020
Applied Biology in Collaboration with Brown Researchers Announce the Discovery of a Possible Association Between the Genetic Cause of Hair Loss and Severity of COVID-19 Infection
Joint Research Effort Points to Possible Genetic Variation that Pre-disposes COVID-19 Patients to Develop Severe Symptoms
- John McCoy, PhD
- ·
- 2019
Identification of the Sulfotransferase Iso-Enzyme Primarily Responsible for the Bio-Activation of Topical Minoxidil
J McCoy, A Goren, T Naccarato1, M Kovacevic, M Situm, VL Skudar, T Lotti. J Biol Regul Homeost Agents
- Andy Goren, MD
- ·
- 2019
History of Vitiligo
Kovacevic Maja, Franceschi Nika, Situm Mirna, Goren Andy, Stanimirovic Andrija, Valle Yan, Lotti Torello. Springer
- Andy Goren, MD
- ·
- 2019
Platelet Rich Plasma in Androgenetic Alopecia: A Systematic Review
Lotti T., Goren A., Verner I. d’Alessio P., Franca K. J.Dermatol Ther.
- Andy Goren, MD, John McCoy, PhD
- ·
- 2019
Integrative Dermatology: The Microbiome in Hair Disorders
Goren A, Situm M, Kovacevic M, McCoy J, Lotti T. Wiley
- Andy Goren, MD
- ·
- 15 March 2018
PHASE I STUDY COMPLETE
Topical Drug for the Treatment of FPHL in Non-responders to 5% Topical Minoxidil
- Andy Goren, MD
- ·
- 5 October 2017
WCHR CONGRESS
Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil
- Andy Goren, MD
- ·
- 22 August 2017
EADV Congress
Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil
- Andy Goren, MD
- ·
- 4 June 2017
NAHRS Congress
α1-AR Agonist Induced Piloerection Protects Against the Development of Traction Alopecia
- John McCoy, PhD
- ·
- 4 May 2015
SID Congress
Novel Diagnostic Test Predicts Mean Change in Hair Counts in Female Androgenetic Alopecia Patients Treated with Topical Minoxidil
Applied Biology is a biotechnology company focusing on hair science. Our development of breakthrough drugs and medical devices for the treatment of hair disorders range from genetic markers to harnessing the power of the microbiome. These landmark developments have allowed us to innovate hair treatments for healthier lives. Our commitment extends beyond product innovation to ethical and sustainable medical practices.